EUVIMEDEUVIMED entdecken
Crossref

Keratinocyte membrane-coated nanoparticle combined with epidermal-targeted microneedle for targeted therapy of atopic dermatitis

Junyang Zhu, Linlin Jia, Xue Liu, Huanhuan Wang, Jinlong Zong, Yingshuang Lv, Jing Hu, Mengjiao Li, Qiaoli Kong, Yan Liu, Qingmei Xia, Han Zhang und 1 weitere

Colloids and Surfaces B: Biointerfaces · 2026-08 · 264 · 115653

DOI: 10.1016/j.colsurfb.2026.115653 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Colloids and Surfaces B: Biointerfaces, 2026-08. Verfasst von Junyang Zhu und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Component Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Engineerin…. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Nanoparticles, Keratinocytes, Epidermis. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Tianjin Municipal Education Commission, National Natural Science Foundation of China, Tianjin Municipal Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysregulated keratinocyte apoptosis contributes to skin barrier impairment and Th2 immune imbalance in atopic dermatitis (AD). To address these issues, we developed MN-HCM@OA-NLC for targeted keratinocyte therapy, enhancing treatment precision and efficacy. The MN-OA-NLC has an insertion depth of approximately 70 μm, which can precisely deliver drugs into the viable epidermis, making the skin retention 2.51-fold that of OA-NLC. Due to the homologous targeting of HCM, the epidermal retention of MN-HCM@OA-NLC is 1.93-fold that of MN-OA-NLC. Totally, the skin retention of MN-HCM@OA-NLC is 16.9-fold higher than that of free OA, providing superior anti-atopic dermatitis efficacy. The MN-HCM@OA-NLC significantly downregulated the expression levels of IL-4, 5, and 13, rebalancing the Th1/Th2 immune response. Additionally, it reduced the epidermal thickness, mast cell count, and IgE expression by 50%, 34%, and 62%, respectively, leading to the alleviation of AD skin lesions. This study introduces a novel strategy that combines efficient delivery with precise targeting for AD treatment, and holds promise for extending therapeutic applications to other inflammatory skin conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicNanoparticlesKeratinocytesEpidermisCell MembraneAnimalsMicroneedle Drug DeliveryHumansDrug Delivery SystemsImmunoglobulin EMice

Stichwörter der Autor:innen

Atopic dermatitisCell membrane-coated nanoparticlesDissolving microneedlesNanostructured lipid carriersOroxylin A

Substanzen

Immunoglobulin E

Autor:innen und Institutionen

  • State Key Laboratory of Component Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Engineering Research Center of Modern Chinese Medicine Discovery and Preparation…
  • Shandong Qidu Pharmaceutical Co., Ltd, Shandong 255400, China.
  • Tianjin Key Laboratory of Optoelectronic Detection Technology and Systems, Tiangong University, Tianjin 300387, China.
  • Chinese Medical College, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
  • State Key Laboratory of Component Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Key Laboratory of Pharmacology of Traditional Chinese Medicine Formulae, Ministr…

Förderung

  • Tianjin Municipal Education Commission
  • National Natural Science Foundation of China
  • Tianjin Municipal Science and Technology Program

Zitieren

APA

Zhu, J., Jia, L., Liu, X., Wang, H., Zong, J., Lv, Y., Hu, J., Li, M., Kong, Q., Liu, Y., Xia, Q., Zhang, H., & Li, N. (2026). Keratinocyte membrane-coated nanoparticle combined with epidermal-targeted microneedle for targeted therapy of atopic dermatitis. Colloids and Surfaces B: Biointerfaces, 264, 115653. https://doi.org/10.1016/j.colsurfb.2026.115653

Vancouver

Zhu J, Jia L, Liu X, Wang H, Zong J, Lv Y, et al. Keratinocyte membrane-coated nanoparticle combined with epidermal-targeted microneedle for targeted therapy of atopic dermatitis. Colloids and Surfaces B: Biointerfaces. 2026;264:115653. doi:10.1016/j.colsurfb.2026.115653

BibTeX
@article{Zhu2026,
  author = {Zhu, Junyang and Jia, Linlin and Liu, Xue and Wang, Huanhuan and Zong, Jinlong and Lv, Yingshuang and Hu, Jing and Li, Mengjiao and Kong, Qiaoli and Liu, Yan and Xia, Qingmei and Zhang, Han and Li, Nan},
  title = {Keratinocyte membrane-coated nanoparticle combined with epidermal-targeted microneedle for targeted therapy of atopic dermatitis},
  journal = {Colloids and Surfaces B: Biointerfaces},
  year = {2026},
  volume = {264},
  pages = {115653},
  doi = {10.1016/j.colsurfb.2026.115653}
}
Kostenlos starten →